The Society of Hospital Medicine (SHM) is a medical society comprised of hospitalists that exists to promote exceptional care for hospitalized patients.
Opioid use disorder (OUD) is the chronic use of opioids that causes clinically significant distress or impairment. Opioid use disorders affect over 16 million people worldwide and over 2.1 million in the United States. Overdose deaths are rising at an unprecedented rate. Highly effective medications for OUD, including methadone and buprenorphine, have the potential to reduce overdose deaths. Yet, relatively few hospitalized patients with opioid-related conditions receive substance use treatment during their inpatient stay making it more likely they will experience subsequent hospitalizations for continued OUD. Hospitalization represents an important opportunity to identify and treat patients with OUD. Hospitalists and other hospital-based clinicians require the knowledge, evidence-based strategies and tools to support the appropriate identification and treatment of hospitalized patients with OUD.
SHM has developed a primer reviewing OUD treatment considerations for the hospitalized patient as well as a discussion guide which may be used in conjunction with the primer to identify optimal strategies for improving care for this patient population.
Learning materials include:
[1] Chang HY, Kharrazi H, Bodycombe D, Weiner JP, Alexander GC. Healthcare costs and utilization associated with high-risk prescription opioid use: a retrospective cohort study. BMC Med. 2018 May 16;16(1):69.
[2] Blanchard J, Weiss AJ, Barrett ML, Stocks C, Owens PL, Coffey R, Heslin KC. Readmissions Following Inpatient Treatment for Opioid-Related Conditions. Subst Use Misuse. 2019;54(3):473-481.
These resources were developed with grant funding provided by Elsevier.
